(CIRB) A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer

GOG-0286B
NCT02065687
Cancer - Corpus Uteri
Krishnansu Tewari
Open
Treatment
Carboplatin, Metformin, Paclitaxel, Paraplatin, Placebo, Taxol
II/III
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.